Didymin, a flavonoid glycoside, has shown potential in various biomedical applications. It is being studied for its anti-cancer properties, particularly in inhibiting the growth of cancer cells and inducing apoptosis. Research suggests it may be effective against liver, breast, and colon cancers. Additionally, didymin exhibits anti-inflammatory and antioxidant effects, making it a candidate for managing chronic inflammatory diseases and oxidative stress-related conditions. It is also being explored for its neuroprotective properties, potentially aiding in the treatment of neurodegenerative disorders like Alzheimer's disease. Furthermore, didymin has demonstrated hepatoprotective effects, which could be beneficial in treating liver damage caused by toxins or diseases. Its potential in enhancing immune response and reducing viral replication is another area of interest, particularly in antiviral therapies. Overall, didymin holds promise as a multifaceted therapeutic agent in modern medicine.